Skip to main content
SpringerLink
Log in

Why does a higher repseonse rate to chemotherapy correlate poorly with improved survival?

  • Editorial
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Cellerino R, Tummarello D, Guidi F, Isidori P, Raspugli M, Biscottini B, Fatati G (1991) A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer. J Clin Oncol 9:1453–1461

    PubMed  Google Scholar 

  • Cellerino R, Tummarello D, Profiri EM, Guidi F, Isidori P, Raspugli M, Biscottini B, Fatati G (1988) Non small cell lung cancer (NSCLC). A prospective randomized trial with alternating chemotherapy CEP/MEC versus no treatment. Eur J Cancer Clin Oncol 24:1839–1843

    PubMed  Google Scholar 

  • Doroshow JH, Multhauf P, Leong L, Margolin K, Litchfield T, Akman S, Carr B, Bertrand M, Goldberg D, Blayney D, Odujinrin O, DeLap R, Shuster J, Newman E (1990) Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy. J Clin Oncol 8:491–501

    PubMed  Google Scholar 

  • Ganz PA, Figlin RA, Haskell CM, La Soto N, Siau J (1988) Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference? Cancer 63:1271–1278

    Google Scholar 

  • Kemeny N, Israel K, Niedzwiecki D, Chapman D, Botet J, Minsky B, Vinciguerra V, Rosenbluth R, Bosselli B, Cochran C, Sheehan K (1990) Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer. J Clin Oncol 8:313–318

    PubMed  Google Scholar 

  • Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207–214

    PubMed  Google Scholar 

  • Rapp E, Pater JL, Willan A, Cormier Y, Murray N, Evans WK, Hodson DI, Clark DA, Feld R, Arnold AM, Ayoub JI, Wilson KS, Latreille J, Wierzbicki RF, Hill DP (1988) Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer-Report of a Canadian multicenter radomized trial. J Clin Oncol 6:633–641

    PubMed  Google Scholar 

  • Woods RL, Williams CJ, Levi J, Page J, Bell D, Byrne M, Kerestes ZL (1989) A randomized trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer. Brit J Cancer 61:608–611

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cleveland Clinic Cancer Center, The Cleveland Clinic Foundation, 44195, Cleveland, Ohio, USA

    Maurie Markman

  2. the Department of Hematology/Medical Oncology, The Cleveland Clinic Foundation, 44195, Cleveland, Ohio, USA

    Maurie Markman

Authors
  1. Maurie Markman
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

The “Journal of Cancer Research and Clinical Oncology” publishes it loose succession “Editorials” and “Guest editorials” on current and/or controversial problems in experimental and clinical oncology. These contributions represent exclusively the personal opinion of the authors The Editors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Markman, M. Why does a higher repseonse rate to chemotherapy correlate poorly with improved survival?. J Cancer Res Clin Oncol 119, 700–701 (1993). https://doi.org/10.1007/BF01195339

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01195339

Search

Navigation